<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">961</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2020-7-8-12-14</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Pharmacy retail in the age of pandemic</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kalinina</surname><given-names>Nadezhda</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">RM Analytiсs Ltd</aff><pub-date date-type="epub" iso-8601-date="2020-12-07" publication-format="electronic"><day>07</day><month>12</month><year>2020</year></pub-date><issue>7-8</issue><fpage>12</fpage><lpage>14</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2020,</copyright-statement><copyright-year>2020</copyright-year></permissions><abstract>The commercial sector of the Russian pharmaceutical market at the first half year-end 2020. The coronavirus infection epidemic, surely, has become one of the central themes of the beginning of the year. In the first half of 2020, the commercial sector of the Russian pharmaceutical market grew by 5% in terms of roubles as compared to the same period last year, but in dollar terms, the growth rates were much lower (-0.5%).</abstract><kwd-group xml:lang="en"><kwd>Nielsen</kwd><kwd>COVID-19</kwd><kwd>pharmacy market</kwd><kwd>rating</kwd><kwd>Nielsen</kwd><kwd>coronavirus</kwd><kwd>pandemic</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аптечный рынок</kwd><kwd>рейтинг</kwd><kwd>коронавирус</kwd><kwd>пандемия</kwd></kwd-group></article-meta></front><body></body><back/></article>
